Trends in average days' supply of opioid medications in Medicaid and commercial insurance

Trends in average days' supply of opioid medications in Medicaid and commercial insurance
复制标题

DOI:
10.1016/j.addbeh.2017.08.005
复制
发表时间:
2018-01-01
影响因子:
4.4
通讯作者:
Mark, Tami L.
Mark, Tami L.
中科院分区:
医学2区
文献类型:
--
作者:
Tehrani, Ali Bonakdar;Henke, Rachel Mosher;Mark, Tami L.

文献摘要

被引文献

相似文献

目的:计算六种常用处方阿片类药物的成人平均日供应趋势:氢可酮、氢吗啡酮、吗啡、羟考酮、羟吗啡酮和他喷他多,以评估医生是否在流行病加剧时改变了处方做法。我们使用2005年-2015年Truven Health MarketScan商业索赔和遭遇数据,以衡量商业保险个人中阿片类药物平均日供应的趋势,2005-2014 MarketScan Multi-State Medicaid data to measure trends in opioid average days' supply among Medicaid beneficiaries.Results:对于Medicaid,我们发现除吗啡外,所有药物的供应天数都有所增加。增加百分比最大的是羟考酮,增加了4.5天(37%)。有商业保险的个人的类阿片日供应量呈现类似但更陡峭的趋势。增加最多的也是羟考酮,增加了6天(56%)。在2013年和2015年之间,当阿片类药物的流行开始被广泛宣传时,任何阿片类药物的中位供应天数都没有下降。结论:我们的研究结果发现,尽管公共卫生运动和媒体关注阿片类药物处方的风险,但阿片类药物的供应天数仍在增加。需要更有效的干预措施来遏制阿片类药物处方,以扭转这些趋势。
Objectives: To calculate trends in adult average days' supply for six commonly prescribed opioids: hydrocodone, hydrorriorphone, morphine, oxycodone, oxymorphone, and tapentadol to assess whether physicians changed prescribing practices at the time'of the intensifying epidemic.Methods: We used 2005-2015 Truven Health MarketScan Commercial Claims and Encounters data to measure trends in opioid average days' supply among commercially insured individuals and 2005-2014 MarketScan Multi-State Medicaid data to measure trends in opioid average days' supply among Medicaid beneficiaries.Results: For Medicaid, we found an increase in days' supply for all drugs except morphine. The largest percentage increase was for oxycodone, which increased 4.5 days (37%). Opioid days' supply for individuals with commercial insurance exhibited similar but steeper trends. The largest increase was also for oxycodone, which increased 6 days (56%). Between 2013 and 2015, when the opioid epidemic had begun to be widely publicized, there was no decline in the median days supplied for any of the opioids.Conclusions: Our results find that days' supply of opioids are increasing despite public health campaigns and media attention on the risks of opioid prescribing. More effective interventions to curb opioid prescribing are needed to reverse these trends.